RU2458691C2 - Лечение посттравматического стрессового расстройства - Google Patents

Лечение посттравматического стрессового расстройства Download PDF

Info

Publication number
RU2458691C2
RU2458691C2 RU2010106014/15A RU2010106014A RU2458691C2 RU 2458691 C2 RU2458691 C2 RU 2458691C2 RU 2010106014/15 A RU2010106014/15 A RU 2010106014/15A RU 2010106014 A RU2010106014 A RU 2010106014A RU 2458691 C2 RU2458691 C2 RU 2458691C2
Authority
RU
Russia
Prior art keywords
nepicastat
difluoro
thioxo
aminomethyl
dihydro
Prior art date
Application number
RU2010106014/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2010106014A (ru
Inventor
Том ВОЙВОДЕ (US)
Том ВОЙВОДЕ
Марк МОРАН (US)
Марк Моран
Original Assignee
Синошиа Терапьютикс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Синошиа Терапьютикс filed Critical Синошиа Терапьютикс
Publication of RU2010106014A publication Critical patent/RU2010106014A/ru
Application granted granted Critical
Publication of RU2458691C2 publication Critical patent/RU2458691C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
RU2010106014/15A 2007-07-23 2008-07-23 Лечение посттравматического стрессового расстройства RU2458691C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93503607P 2007-07-23 2007-07-23
US60/935,036 2007-07-23

Publications (2)

Publication Number Publication Date
RU2010106014A RU2010106014A (ru) 2011-08-27
RU2458691C2 true RU2458691C2 (ru) 2012-08-20

Family

ID=40281815

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010106014/15A RU2458691C2 (ru) 2007-07-23 2008-07-23 Лечение посттравматического стрессового расстройства

Country Status (12)

Country Link
US (1) US20090054403A1 (cg-RX-API-DMAC7.html)
EP (1) EP2182952A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010534676A (cg-RX-API-DMAC7.html)
CN (1) CN101951912A (cg-RX-API-DMAC7.html)
AU (1) AU2008279091A1 (cg-RX-API-DMAC7.html)
CA (1) CA2707858A1 (cg-RX-API-DMAC7.html)
CO (1) CO6260078A2 (cg-RX-API-DMAC7.html)
MX (1) MX2010000937A (cg-RX-API-DMAC7.html)
NZ (1) NZ583193A (cg-RX-API-DMAC7.html)
RU (1) RU2458691C2 (cg-RX-API-DMAC7.html)
SG (1) SG183069A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009015248A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2614697C1 (ru) * 2016-04-12 2017-03-28 Общество с ограниченной ответственностью "Нормофарм" Нейропротекторное средство

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010000938A (es) * 2007-07-23 2010-07-01 Synosia Therapeutics Inc Uso de (4-metoxi-7-morfolin-4-il-benzotiazol-2-il)-amida del ácido 4-hidroxi-4-metil-piperidin-1-carboxílico para el tratamiento del trastorno por estrés postraumático.
RU2491067C2 (ru) * 2007-08-06 2013-08-27 Байотай Терапис, Инк Способы лечения зависимости
AU2016208412A1 (en) * 2007-08-06 2016-08-18 Biotie Therapies, Inc. Methods for treating dependence
PT2501234T (pt) * 2009-11-20 2017-12-13 Tonix Pharma Holdings Ltd Métodos e composições para o tratamento de sintomas associados com distúrbios de stress pós-traumático utilizando ciclobenzaprina
US20110319389A1 (en) 2010-06-24 2011-12-29 Tonix Pharmaceuticals, Inc. Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US11998516B2 (en) 2011-03-07 2024-06-04 Tonix Pharma Holdings Limited Methods and compositions for treating depression using cyclobenzaprine
MY196014A (en) 2013-03-15 2023-03-06 Tonix Pharmaceuticals Inc Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride
EP3074525B1 (en) * 2013-11-26 2024-06-26 University of North Texas Health Science Center at Fort Worth Personalized medicine approach for treating cognitive loss
SG10201902203VA (en) 2014-09-18 2019-04-29 Tonix Pharma Holdings Ltd Eutectic formulations of cyclobenzaprine hydrochloride
JOP20190049A1 (ar) 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز
US10588890B2 (en) * 2017-05-30 2020-03-17 Biommunity, Inc. Compositions and methods to regulate hormonal cascades in stress disorders
AU2018204843B2 (en) * 2017-07-05 2023-07-27 Medtronic Ardian Luxembourg S.A.R.L. Methods for treating anxiety disorders in patients via renal neuromodulation
WO2019112457A1 (en) 2017-12-04 2019-06-13 BIAL - PORTELA & Cª, S.A. Dopamine-β-hydroxylase inhibitors
BR112020011345A2 (pt) 2017-12-11 2020-11-17 Tonix Pharma Holdings Limited tratamento com ciclobenzaprina para agitação, psicose e declínio cognitivo na demência e condições neurodegenerativas
CN109966281B (zh) * 2019-04-11 2021-04-27 北京大学 PAO作为Pi4KIIα抑制剂在制备治疗创伤后应激障碍药物中的应用
JP7618230B2 (ja) * 2019-07-25 2025-01-21 学校法人東京理科大学 精神・神経系の疾患又は症状を治療し、予防し又は改善する剤
CN120882371A (zh) * 2022-11-30 2025-10-31 闪烁实验室有限公司 使用眼睑跟踪的精神药理学系统和方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391922B1 (en) * 1998-01-13 2002-05-21 Synchroneuron, Llc Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
EP1425017A1 (en) * 2001-09-13 2004-06-09 Schering Corporation Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic
EP1336406A1 (en) * 2002-02-14 2003-08-20 Solvay Pharmaceuticals B.V. Partial dopamine-D2 receptor agonist plus serotonin and/or noradrenaline inhibitory activity
MXPA04011529A (es) * 2002-04-24 2005-08-15 Cypress Bioscience Inc Prevencion y tratamiento de trastornos somaticos funcionales, incluyendo trastornos relacionados con la tension.
WO2005079756A2 (en) * 2004-02-13 2005-09-01 Neuromolecular, Inc. Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
EP1858515A2 (en) * 2005-03-04 2007-11-28 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
CN101257907A (zh) * 2005-07-06 2008-09-03 塞普拉科公司 左旋佐匹克隆和抗抑郁剂的组合
US20100105748A1 (en) * 2007-03-16 2010-04-29 David Weinshenker Methods and compositions for treatment of drug addiction
WO2009015244A1 (en) * 2007-07-23 2009-01-29 Synosia Therapeutics Rufinamide for the treatment of post-traumatic stress disorder

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
КОСОВА Е.Г. Психическая ригидность как фактор развития посттравматического стрессового расстройства у сотрудников оперативных подразделений, перенесших боевой стресс. Диссертация. - Томск, 2005. PETRAKIS I.L. et al. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biol Psychiatry. 2006 Oct 1; 60(7):777-783. STANLEY W.C. et al. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Br J Pharmacol. 1997 Aug; 121(8): 1803-1809. HAMNER M.B. Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder. Psychiatry Res. 1998 Feb 27; 77(3): 175-181. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2614697C1 (ru) * 2016-04-12 2017-03-28 Общество с ограниченной ответственностью "Нормофарм" Нейропротекторное средство

Also Published As

Publication number Publication date
JP2010534676A (ja) 2010-11-11
CA2707858A1 (en) 2009-01-29
WO2009015248A1 (en) 2009-01-29
AU2008279091A1 (en) 2009-01-29
US20090054403A1 (en) 2009-02-26
MX2010000937A (es) 2010-06-25
RU2010106014A (ru) 2011-08-27
EP2182952A1 (en) 2010-05-12
EP2182952A4 (en) 2010-09-08
CN101951912A (zh) 2011-01-19
SG183069A1 (en) 2012-08-30
NZ583193A (en) 2012-05-25
CO6260078A2 (es) 2011-03-22

Similar Documents

Publication Publication Date Title
US20200383951A1 (en) Methods for treating dependence
US20090054403A1 (en) Treatment of Post-Traumatic Stress Disorder
EP3013342B1 (en) Adrenoceptors antagonists for the prevention and treatment of neurodegenerative conditions
WO2010124089A2 (en) Methods for treating dependence
KR101996108B1 (ko) 부프레놀핀 및 뮤-오피오이드 수용체 길항물질의 조성물
US20240277732A1 (en) Compositions and methods for treating brain-gut disorders
AU2018203524B2 (en) Methods for treating dependence
EP4009942B1 (en) Compound for combination treatment
Merello et al. Cardiovascular reflexes in Parkinson's disease: effect of domperidone and apomorphine
AU2014202047A1 (en) Methods for treating dependence
WO2014005720A1 (en) Use of (r)-phenylpiracetam for the treatment of disease-associated fatigue
HK1155063A (en) Treatment of post-traumatic stress disorder
HK1241721A1 (en) Methods for treating dependence
Rapole et al. Comparative Study of Atenolol And Nebivolol on Hypertension And Heart Rate in Hypertensive Patients
HK40071713A (en) Compound for combination treatment
HK40071713B (en) Compound for combination treatment
HK1143038A (en) Methods for treating dependence
STEINHEYER et al. Basic and Clinical Aspects of Depression

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130724